Literature DB >> 6881930

Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate.

R J Allen, S DiMauro, D L Coulter, A Papadimitriou, S P Rothenberg.   

Abstract

A young woman with Kearns-Sayre syndrome and progressive central nervous system deterioration over 15 years had decreased plasma and cerebrospinal fluid folate levels while receiving phenytoin for a seizure disorder. A muscle biopsy showed a "ragged red fiber" myopathy with reduced muscle carnitine and mitochondrial enzymes. Computed tomographic brain scans showed cerebral white matter hypodensities and bilateral calcification of the basal ganglia. The mechanism for the folate deficiency and altered ratio of plasma to cerebrospinal fluid folate is unknown, but the deficiency may be responsive to replacement therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6881930     DOI: 10.1002/ana.410130620

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

Review 1.  Defects in the mitochondrial energy metabolism outside the respiratory chain and the pyruvate dehydrogenase complex.

Authors:  F J Trijbels; W Ruitenbeek; M Huizing; U Wendel; J A Smeitink; R C Sengers
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

2.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration.

Authors:  M Yamamoto; T Sato; M Anno; H Ujike; M Takemoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

3.  Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system.

Authors:  R A Wevers; S I Hansen; J L van Hellenberg Hubar; J Holm; M Høier-Madsen; P J Jongen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

4.  CSF concentrations of 5-methyltetrahydrofolate in a cohort of young children with autism.

Authors:  John Shoffner; Barbara Trommer; Audrey Thurm; Cristan Farmer; William A Langley; Laura Soskey; Aldeboran N Rodriguez; Precilla D'Souza; Sarah J Spence; Keith Hyland; Susan E Swedo
Journal:  Neurology       Date:  2016-05-13       Impact factor: 9.910

5.  Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience.

Authors:  Marta Batllori; Marta Molero-Luis; Aida Ormazabal; Raquel Montero; Cristina Sierra; Antonia Ribes; Julio Montoya; Eduardo Ruiz-Pesini; Mar O'Callaghan; Leticia Pias; Andrés Nascimento; Francesc Palau; Judith Armstrong; Delia Yubero; Juan D Ortigoza-Escobar; Angels García-Cazorla; Rafael Artuch
Journal:  J Inherit Metab Dis       Date:  2018-07-04       Impact factor: 4.982

6.  Defects in the cytochrome bc1 complex in mitochondrial diseases.

Authors:  N G Kennaway
Journal:  J Bioenerg Biomembr       Date:  1988-06       Impact factor: 2.945

7.  Mitochondrial Disease.

Authors:  Roser Pons; Darryl C. De Vivo
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

Review 8.  Cerebral folate deficiency.

Authors:  Keith Hyland; John Shoffner; Simon J Heales
Journal:  J Inherit Metab Dis       Date:  2010-07-29       Impact factor: 4.982

Review 9.  Drugs and folate metabolism.

Authors:  D G Lambie; R H Johnson
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

Review 10.  Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Mary Kay Koenig; Fernando Scaglia; Gregory M Enns; Russell Saneto; Irina Anselm; Bruce H Cohen; Marni J Falk; Carol Greene; Andrea L Gropman; Richard Haas; Michio Hirano; Phil Morgan; Katherine Sims; Mark Tarnopolsky; Johan L K Van Hove; Lynne Wolfe; Salvatore DiMauro
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.